Back
Quest Diagnostics 10K Form
Buy
54
DGX
Quest Diagnostics
Last Price:
132.44
Seasonality Move:
14.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-02-22 | 10K | DGX/Quest Diagnostics Annual |
2023-10-25 | 10Q | DGX/Quest Diagnostics Quarterly |
2023-07-27 | 10Q | DGX/Quest Diagnostics Quarterly |
2023-04-28 | 10Q | DGX/Quest Diagnostics Quarterly |
2023-02-21 | 10K | DGX/Quest Diagnostics Annual |
2022-10-21 | 10Q | DGX/Quest Diagnostics Quarterly |
Receive DGX News And Ratings
See the #1 stock for the next 7 days that we like better than DGX
DGX Financial Statistics
Sales & Book Value
Annual Sales: | $9.25B |
---|---|
Cash Flow: | $455M |
Price / Cash Flow: | 17.18 |
Annual Sales: | $56.60 |
Price / Book: | 2.3 |
Profitability
EPS (TTM): | 7.49000 |
---|---|
Net Income (TTM): | $854M |
Gross Margin: | $3.05B |
Return on Equity: | 13.56% |
Return on Assets: | 6.42% |
Quest Diagnostics Earnings Forecast
Key Quest Diagnostics Financial Ratios
- The Gross Profit Margin over the past 28 years for DGX is 33.00%.
- The Selling, General & Administrative Expenses for DGX have been equal to 17.75% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 19.09% of Operating Income.
- The Net Earning history of DGX is 9.23% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 19 years.
Quest Diagnostics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Diagnostics & Research |
Sector: | Healthcare |
Current Symbol: | DGX |
CUSIP: | 74834L |
Website: | questdiagnostics.com |
Debt
Debt-to-Equity Ratio: | 0.77 |
---|---|
Current Ratio: | 1.31 |
Quick Ratio: | 1.04 |
Price-to-Earnings
Trailing P/E Ratio: | 17.5 |
---|---|
Forward P/E Ratio: | 13.93 |
DGX Technical Analysis vs Fundamental Analysis
Buy
54
Quest Diagnostics (DGX)
is a Buy
Is Quest Diagnostics a Buy or a Sell?
-
Quest Diagnostics stock is rated a Buy
The current Quest Diagnostics [DGX] share price is $131.06. The Score for DGX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.